U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H15N3O
Molecular Weight 217.267
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-(2-KETO-1-BENZIMIDAZOLINYL)PIPERIDINE

SMILES

O=C1NC2=CC=CC=C2N1C3CCNCC3

InChI

InChIKey=BYNBAMHAURJNTR-UHFFFAOYSA-N
InChI=1S/C12H15N3O/c16-12-14-10-3-1-2-4-11(10)15(12)9-5-7-13-8-6-9/h1-4,9,13H,5-8H2,(H,14,16)

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/28218826

4-(2-Keto-1-benzimidazolinyl)piperidine is building block for preparing potent anticancer compounds.

Originator

Stoerk, H.C|Arison, R.N|Hawkins, J.E.Jr.
1
Sources: Nature (1957), 180, (4599), 1428-9.

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
N-acylated alpha-(3-pyridylmethyl)-beta-aminotetralin antagoinists of the human neuropeptide Y Y5 receptor.
2000 Aug 7
SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists.
2005 Aug 1
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors.
2005 Mar 15
The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors.
2006 Apr 15
Patents

Patents

04902799
3
05574044
3
06410792
1
06841552
1
07834000
2
08003669
5
08637496
1
JPS5639086A
1

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Compound (3, 4-(2-Keto-1-benzimidazolinyl)piperidine) activity was evaluated by annexin V/propidium iodide staining-based flow cytometric analysis in human K562 cells after 48h of treatment.
Name Type Language
4-(2-KETO-1-BENZIMIDAZOLINYL)PIPERIDINE
Systematic Name English
4-(2-OXO-1,3-DIHYDROBENZIMIDAZOL-1-YL)PIPERIDINE
Systematic Name English
R-30507
Code English
4-(2-OXO-1-BENZIMIDAZOLINYL)PIPERIDINE
Systematic Name English
1-(4-PIPERIDINYL)-2-BENZIMIDAZOLONE
Systematic Name English
2H-BENZIMIDAZOL-2-ONE, 1,3-DIHYDRO-1-(4-PIPERIDINYL)-
Systematic Name English
1-(PIPERIDIN-4-YL)-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE
Systematic Name English
PIMOZIDE IMPURITY A [EP IMPURITY]
Common Name English
4-(2-OXO-1-BENZIMIDAZOLY)PIPERIDINE
Systematic Name English
4-(2-OXO-1,3-DIHYDRO-2H-BENZIMIDAZOL-1-YL)PIPERIDINE
Systematic Name English
Code System Code Type Description
FDA UNII
4RP0AED2PC
Created by admin on Sat Dec 16 08:23:54 GMT 2023 , Edited by admin on Sat Dec 16 08:23:54 GMT 2023
PRIMARY
CAS
20662-53-7
Created by admin on Sat Dec 16 08:23:54 GMT 2023 , Edited by admin on Sat Dec 16 08:23:54 GMT 2023
PRIMARY
ECHA (EC/EINECS)
243-950-3
Created by admin on Sat Dec 16 08:23:54 GMT 2023 , Edited by admin on Sat Dec 16 08:23:54 GMT 2023
PRIMARY
EPA CompTox
DTXSID0057679
Created by admin on Sat Dec 16 08:23:54 GMT 2023 , Edited by admin on Sat Dec 16 08:23:54 GMT 2023
PRIMARY
PUBCHEM
88638
Created by admin on Sat Dec 16 08:23:54 GMT 2023 , Edited by admin on Sat Dec 16 08:23:54 GMT 2023
PRIMARY
PARENT (METABOLITE)
Structure of PIMOZIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966